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Background: There is a paucity of data on the trends in discharge disposition for patients undergoing
hepatic resection for malignancy.
Aim: To analyse the national trends in discharge disposition after hepatic resection for malignancy.
Methods: The National Inpatient Sample (NIS) database was queried (1993 to 2005) to identify patients
that underwent hepatic resection for malignancy and analyse the discharge status (home, home health or
rehabilitation/skilled facility).
Results: A weighted total of 74 520 patients underwent hepatic resection of whom, 53 770 patients had
a principal diagnosis of malignancy. The overall mortality improved from 6.3% to 3.4%. After excluding
patients that died in the post-operative period and those with incomplete discharge status, 45 583
patients were included. The proportion of patients that had acute care needs preventing them from being
discharged home without assistance increased from 10.9% in 1993 to 19.5% in 2005. While there was an
increase in the number of patients discharged to home health care during this time (8.9% to 13.8%), there
was a larger increase in the proportion of patients that were discharged to a rehabilitation or skilled
nursing facility (2% to 5.7%). Despite a decrease in the mortality rates, there was no improvement in rate
of patients discharged home without assistance over the period of the study.
Conclusions: The results of the present study demonstrate that after hepatic resection, a significant
proportion of patients will need assistance upon discharge. This information needs to be included in
patient counselling during pre-operative risk and benefit assessment.
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Introduction
Hepatic resection is increasingly performed in the United States
for various malignancies involving the liver.1,2 Hepatic resection is
considered to be the only modality that offers the hope of long-
term survival for patients with metastatic colorectal cancer
with reported 5-year survival rates ranging from 19% to 47%.3–5
Similarly, hepatic resection is a vital part of the algorithm in the
treatment of patients with primary hepatic malignancies.6 Several
reports with large numbers of patients have demonstrated the
safety of hepatic resection with acceptable mortality rates.7–11
Despite the low mortality rates, the morbidity rates continue to
remain high ranging from 14% to 54%.7–10 The presence of post-
operative morbidity determines the length of stay and the final
discharge disposition. It is presumed that some patients are not
candidates to be discharged home because of their post-operative
course. There is a paucity of data on the national trends in
discharge disposition after hepatic resection for malignancy. This
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information is important as it needs to be included in the pre-
operative counselling of risks and benefits with the patients. The
aims of the present study were to: (i) analyse the national trends in
discharge disposition after hepatic resection for malignancy, and
(ii) determine the factors that influence the discharge disposition.
Materials and methods
The Nationwide Inpatient Sample (NIS) database was utilized to
analyse the trends in discharge status after hepatic resection for
malignancy. Data were obtained from the NIS database developed
as part of the Healthcare Cost and Utilization Project (HCUP),
sponsored by the Agency for Healthcare Research and Quality.
The NIS is designed to approximate a 20% sample of US commu-
nity hospitals. In 2005, the NIS data contained discharge data
from 1054 hospitals located in 37 states.
The NIS database was queried (1993 to 2005) to identify
patients that underwent hepatic resection for malignancy. Patients
that underwent hepatic resection for benign conditions were
excluded. Data on patient age and gender, admission type,
hospital size and type, diagnosis, presence of pre-operative
co-morbidities, race, income, extent of resection and length of
stay were extracted from the database.
Co-morbid conditions were identified using the taxonomy
published by Elixhauser.12 The status of patients at discharge was
noted. ‘Home’ was defined as patients that were discharged home
with no health assistance. ‘Rehabilitation or skilled facility’ was
defined as patients that were discharged or transferred to a skilled
nursing, sub-acute care or nursing facility. ‘Home health care’ was
defined as patients that were discharged home but needed the
assistance of a visiting nurse or other skilled health care personnel.
For further analysis, ‘Rehabilitation or skilled facility’ and ‘home
health care’ were grouped under ‘Non-routine’.
Statistical methods
SAS software (SAS Institute Inc., Cary, NC, USA) and SUDAAN
software were used for all statistical analysis to account for the
complex sampling design of NIS. Weighted sample estimates,
standard errors and 95% confidence limits (CL) were calculated
using the Taylor expansion method. All statistical tests were two-
sided and P-values less than 0.05 are considered to be statistically
significant.
Cochran–Mantel–Haenszel ANOVA-type test for trend was
used to compare changes in discharge status over time. Chi-square
tests were used to compare patient characteristics by discharge
status throughout the entire study period. A multivariate logistic
regression model was fit to predict the probability of a routine
discharge with the significant variables (at the 0.01 level) in the
univariate analysis as predictor variables. We also examined an
additional model looking at age and number of comorbidities as
a combination group variable; this model was adjusted for year,
diagnosis group, procedure type and length of stay.
Results
Between 1993 and 2005, a weighted total of 74 520 patients under-
went hepatic resection (lobectomy or wedge resection) as the
principal procedure. Of those, 53 770 patients had a principle
diagnosis of malignant neoplasm involving the liver (primary or
metastatic). After excluding patients that died in the post-
operative period, those that left against medical advice, and those
that did not have a post-hospital disposition indicated, 45 583
patients were included in the study. The overall mortality rate
showed an improvement over the period of the study from 6.3%
in 1993 to 3.4% in 2005.
The discharge disposition of all included patients over the
period of the study is shown in Fig. 1: a decrease in the number of
patients in the ‘Home’ group by almost 10% was noted. Similarly,
the proportion of patients that had acute care needs preventing
them from being discharged home without assistance (‘Rehabili-
tation or skilled’+ ‘home health care’) which would be classified as
non-routine increased from 10.9% in 1993 to 19.5% in 2005 (P =
0.0042) (Fig. 1). While there was an increase in the number of
patients discharged to ‘home health care’ by 55% (8.9% to 13.8%)
during this time, there was a larger increase in the proportion of
patients that were discharged to a ‘Rehabilitation or Skilled’
facility by 185% (2% to 5.7%). Univariate analysis of the influence
of various variables on the discharge disposition is shown in
Table 1. The primary diagnosis, extent of resection, age, presence
of pre-operative co-morbidities, race and length of stay were
noted to have a statistically significant influence on the discharge
disposition.
Table 2 shows the results of a multivariate logistic regression
analysis of the influence of various variables on the discharge
disposition. Several variables such as age, number of co-
morbidities and length of stay were noted to have a significant
influence on the discharge disposition. Patients with a length of
stay of more than 10 days were 76% less likely to have a routine
discharge (Table 2). Those greater than 70 years old were 65%
less likely to have a routine discharge. Although the ‘home’ dis-
charge rate remained the same in the less than 70 years age
group, we noted a significant decrease in the older group of
patients (Fig. 2). Patients with three or more co-morbidities
were 32% less likely to have a routine discharge than those with
less than three co-morbidities. Within the group of patients with
more than three co morbidities we noted a decrease in the
‘home’ discharge rate over the period of the study (Fig. 3). The
interaction between age and co-morbidities was not significant
in the multivariate model (P = 0.55). Even though the interac-
tion was not significant we created an age/co-morbidities com-
bination variable as a predictor of ‘home’ discharge while
adjusting for primary diagnosis, extent of resection and length of
stay. Patients older than 70 years of age and having more than
three pre-operative co-morbidities had the lowest possibility of a
routine discharge (24% less likely than the reference group of
<70 years and <3 co-morbidities).
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An analysis of numerical trends of the significant variables
(age and co-morbidities), demonstrated a slight change in the age
distribution over the period of the study, with a decrease in the
proportion of older age patients (Table 3). In contrast, the study
noted a larger increase in the proportion of patients with greater
than three co morbidities (48% in 1993 to 64% in 2005).
Discussion
The results of the present study show that fewer patients are being
discharged home after hepatic resection for malignancy. Of the
patients that were not discharged home we noted a significant
increase in the number of patients being discharged to Rehabili-
tation or skilled facilities during the study period. This is despite
the fact that there is a noted improvement in the mortality rates
over the period of the study.
The significant factors shown to have an influence on the dis-
charge disposition are age, pre-operative co-morbidities and
length of stay. Several reports have demonstrated the safety of
hepatic resection in the elderly.13–15 These reports documented
mortality and morbidity rates that were similar to younger
patients.13–15 Although the mortality rate in the present study is in
the currently acceptable range, we noted that older patients are
less likely to go home directly and this trend increased throughout
the time period of the study. This is despite the finding of a slight
decrease in the proportion of hepatic resections performed in
the older age group during the period of the study (Table 3).
The reasons for this are unclear but it is likely that although the
elderly have equivalent immediate peri-operative outcomes, a
prolonged recovery period or possibly greater complications or
co-morbidities prevent them from going home. A recent 20-year
multicentre Italian Liver group experience concluded that the
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Figure 1 Trends in discharge disposition over the period of the study
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overall applicability of radical or effective hepatocellular carci-
noma (HCC) treatments was unaffected by old age but they did
notice a trend that patients older than 70 years are now offered
more percutaneous treatments than hepatic resection or tran-
scatheter arterial chemoembolization (TACE).16
Similarly, it is well known that the presence of pre-operative
co-morbidities can have an influence on post-operative outcomes
and thereby the discharge disposition.7,8 A prospective study of the
National Surgical Quality Improvement Program (NSQIP) data
identified pre-operative factors such low serum albumin, serum
glutamic oxaloacetic transaminase (SGOT) > 40 units/l, previous
cardiac operation, and severe chronic obstructive pulmonary
disease (COPD) would increase post-operative morbidity after
liver resection.17 The same study identified male gender, American
Society of Anesthesiologists (ASA) class III or higher, presence of
ascites, dyspnoea and severe COPD as factors influencing mortal-
ity.17 Similarly, a recent analysis of NSQIP patients that underwent
hepatic resection documented a mortality and morbidity rate of
2.5% and 19.6%, respectively.11 They identified several
co-morbidities such as nutritional status, liver function and extent
of hepatic resection that had an influence on post-operative
outcome. An adverse post-operative outcome is likely to have a
bearing on the discharge disposition.11The present study demon-
strated that although we are operating on the same percentage of
older patients, there was a noted increase in the number of
patients with greater than three co-morbidities (Table 3). This
trend may be contributing to a decrease in the rate of patients
being discharged to ‘home’ and an increase in the need for reha-
bilitation or a skilled facility to recuperate after a major hepatic
resection. The group with the least chance of going home was
Table 1 Univariate analysis of the influence of various factors on discharge disposition, years 1993–2005 combined
n Home % Non-routine % P
Extent of resection
=lobectomy 20 415 81 19 0.0089
=wedge resection 25 167 83 17
Diagnosis
=Primary 12 268 79 21 <0.0001
=Metastasis 33 314 83 17
Age (years)
<70 33 140 87 13 <0.0001
70 12 442 69 31
Co- morbidities
2 20 147 87 13 <0.0001
3 25 436 78 22
Size
=Small 3 737 80 20 0.78
=Medium 6 752 82 18
=Large 35 070 82 18
Hospital
=non-teaching 10 184 82 18 0.88
=teaching 35 374 82 18
Race
=non-white 9 230 85 15 0.018
=white 28 038 81 19
Income
=1–24 999 6 567 79 21 0.091
25 000–34 999 11 785 82 18
35 000–44 900 10 579 82 18
45 000 and up 13 797 83 17
Length of stay
10 days 35 673 87 13 <0.0001
>10 days 9 909 64 36
Non-routine: includes Rehabilitation/skilled nursing facility and home health care.
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Table 2 Multivariate model of the probability of a Home discharge compared with non-routine, using a logistic regression model
Odds Ratio Lower 95% CI Upper 95% CI P
Year 1993 3.05 2.01 4.65 <0.0001
1994 2.18 1.27 3.72
1995 1.33 0.79 2.25
1996 1.16 0.70 1.91
1997 1.56 1.02 2.39
1998 1.03 0.66 1.61
1999 1.50 0.90 2.51
2000 1.14 0.74 1.75
2001 1.14 0.77 1.71
2002 1.46 0.86 2.47
2003 0.71 0.44 1.17
2004 0.93 0.61 1.44
2005 Ref. – –
Cancer Group Primary 0.88 0.76 1.03 0.10
Metastases Ref. – –
Procedure Lobectomy 0.91 0.80 1.04 0.19
Wedge Resection Ref. – –
Age group <70 years Ref. – – <0.0001
70+ years 0.35 0.31 0.40
Number of co-morbidities under 3 Ref. – – <0.0001
3 or more 0.68 0.59 0.78
Length of stay 10 days or less Ref. – – <0.0001
More than 10 days 0.24 0.20 0.29
Presented are odds ratios with 95% confidence intervals (CI).
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Figure 2 Rate (percentage) of ‘home’ discharge based on age
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patients older than 70 years of age and the concomitant presence
of three or more pre-operative co-morbidities (Table 2).
The length of stay was also noted to be longer in patients in the
‘non-routine’ group. It is well known that length of stay correlates
with post-operative course/complications and can therefore influ-
ence discharge disposition. The NSQIP analysis of 2313 elective
open hepatic resections documented that patients with a post-
operative major morbidity had a longer median length of stay
(10 vs. 6 days,P= 0.001) and higher mortality rate (11.3% vs. 0.3%;
P = 0.001).11
There are several limitations to a study of this nature. The NIS
database does not provide for detailed analysis of post-operative
complications. The type and severity of post-operative complica-
tions can have a significant bearing on the discharge disposition. It
is possible that analysis of post-operative complications can help
in identifying the sub-group of patients that are less likely to be
routinely discharged. The NIS database does not contain informa-
tion regarding administration of chemotherapy. Various authors
have noted that pre-operative chemotherapy can cause sinusoidal
congestion18 and steatohepatitis19 and these changes can have an
adverse influence on post-operative outcomes.20,21 Kooby et al.22
demonstrated the adverse influence of hepatic steatosis on mor-
bidity after hepatic resection. The advent of modern chemo-
therapy has led to an increase in the utilization of the newer drugs5
for patients with advanced colorectal cancer. It is likely that the
increasing utilization of chemotherapy may contribute to post-
operative complications that can affect the discharge disposition.
Lastly, the current state of health care in the United States places
an emphasis on discharging patients as soon as possible from an
acute care setting. This is in contrast to health policies several
years ago when patients stayed in the hospital until they were fit to
be discharged home. This change in discharge planning may also
confound the results of our retrospective study.
The present study did not analyse the outcomes pertaining to
patients that underwent minimally invasive hepatic resection. It is
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Figure 3 Rate (percentage) of ‘home’ discharge based on presence of co-morbidities
Table 3 Trends in the number of patients based on age and pres-
ence of co-morbidities (1993–2005)
Year Age (years) Co-morbidities
<70 years old 70+ years old 3 or more under 3
1993 75.03% 24.97% 48.41% 51.59%
1994 70.79% 29.21% 47.94% 52.06%
1995 69.36% 30.64% 54.72% 45.28%
1996 68.62% 31.38% 55.93% 44.07%
1997 72.22% 27.78% 52.96% 47.04%
1998 71.01% 28.99% 57.21% 42.79%
1999 71.22% 28.78% 57.11% 42.89%
2000 71.44% 28.56% 54.61% 45.39%
2001 71.41% 28.59% 53.69% 46.31%
2002 75.14% 24.86% 55.13% 44.87%
2003 74% 26% 57.45% 42.55%
2004 75.6% 24.4% 61.27% 38.73%
2005 75.76% 24.24% 64.07% 35.93%
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well known that minimally invasive hepatectomy is safe, feasible
and associated with comparable or better peri-operative out-
comes.23,24 It is likely that the discharge disposition can be influ-
enced in the future by the increasing number of minimally
invasive hepatic resections.
The relevance of the present study results is that it provides a
temporal trend to a type of outcome that is not widely reported.
These data are important for other reasons as well as assessing the
overall cost of healthcare that goes beyond the analysis of the
immediate operative and perioperative utilization of resources. It
is likely that patients that do not go home incur a differential
pattern of health care expenses and this needs to be conveyed
to the patients. Unlike the length of stay, factors such as age,
co-morbidities, diagnosis and type of resection are usually known
pre-operatively. The likelihood of being discharged to home based
on the presence or absence of the above factors needs to be
included in the pre-operative counselling of the risks and benefits
of the proposed hepatic resection.
In summary, despite a declining mortality rate, the results of the
present study demonstrated a decrease in the number of patients
being discharged home after hepatic resection for malignancy.
Further studies to analyse the contributing factors in detail are
essential but some risk factors include age greater than 70 years,
presence of three or more co-morbidities and an increased post-
operative length of stay. This information needs to be included in
the pre-operative counselling of the individual patient and is also
important in the broader context of assessing health care costs and
resource utilization.
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